Cargando…

Effects of low-dose capecitabine on Samarium-153-EDTMP therapy for painful bone metastases

INTRODUCTION: Samarium-153 (Sm-153)-EDTMP is routinely used for pain palliation in skeletal metastasis, however most patients report partial response. Many strategies have been contemplated to make radiation therapy for pain more effective, one of them being the use of radiosensitizers. Capecitabine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barai, Sukanta, Gambhir, Sanjay, Rastogi, Neeraj, Mandani, Anil, Siddegowda, Murthy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379668/ https://www.ncbi.nlm.nih.gov/pubmed/25829727 http://dx.doi.org/10.4103/0972-3919.152955

Ejemplares similares

Beyond Palliation: Therapeutic Applications of (153)Samarium-EDTMP
por: Wilky, Breelyn A., et al.
Publicado: (2013)

Treatment efficacy of (153)Sm-EDTMP for painful bone metastasis
por: Ayati, Narjess, et al.
Publicado: (2013)

The Level of Europium-154 Contaminating Samarium-153-EDTMP Activates the Radiation Alarm System at the US Homeland Security Checkpoints
por: Najeeb Al Hallak, Mohammed, et al.
Publicado: (2009)

Comparative Therapeutic Efficacy of (153)Sm-EDTMP and (177)Lu-EDTMP for Bone Pain Palliation in Patients with Skeletal Metastases: Patients’ Pain Score Analysis and Personalized Dosimetry
por: Sharma, Sarika, et al.
Publicado: (2017)

Samarium-153-EDTMP (Quadramet(®)) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial
por: Heery, Christopher R., et al.
Publicado: (2016)

Radionuclide Treatment with 153Sm-EDTMP is Effective for the Palliation of Bone Pain in the Context of Extensive Bone Marrow Metastases: A Case Report
por: Kairemo, Kalevi, et al.
Publicado: (2014)

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases
por: Lam, Marnix G. E. H., et al.
Publicado: (2007)

Evaluation of Basal Renal Function in Treatment-naïve Patients with Malignancy and Comparison with Age Matched Healthy Control
por: Barai, Sukanta, et al.
Publicado: (2016)

Comparison of Tc-99m MDP and Sm-153 EDTMP bone scan
por: Ramachandran, Krishnakumar, et al.
Publicado: (2011)

Treatment of severe hypocalcaemia due to osteoblastic metastases in a patient with post-thyroidectomy hypoparathyroidism with (153)Sm-EDTMP
por: Kassi, Eva, et al.
Publicado: (2017)

Toxicity of Therapy with Sm-153-EDTMP: To What Extend can it be Related to the Tumor Type?
por: Świętaszczyk, Cyprian, et al.
Publicado: (2016)

Optimal Timing of Bisphosphonate Administration in Combination with Samarium-153 Oxabifore in the Treatment of Painful Metastatic Bone Disease
por: Rasulova, Nigora, et al.
Publicado: (2013)

[(153)Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
por: Kratochwil, Clemens, et al.
Publicado: (2021)

Samarium-153-ethylene diamine tetramethylene phosphonate, a beta-emitting bone-targeted radiopharmaceutical, useful for patients with osteoblastic bone metastases
por: Longo, John, et al.
Publicado: (2013)

Effect of Mirtazapine on Gastric Emptying in Patients with Cancer-associated Anorexia
por: Kumar, N, et al.
Publicado: (2017)

Separation of samarium and europium by solvent extraction with an undiluted quaternary ammonium ionic liquid: towards high-purity medical samarium-153
por: Van de Voorde, Michiel, et al.
Publicado: (2018)

Synovectomy using Samarium-153 Hydroxyapatite in the Elbows and Ankles of Patients with Hemophilic Arthropathy
por: Manzzini Calegaro, José Ulisses, et al.
Publicado: (2018)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [$^{153}$Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [(153)Sm]Sm-DOTA-TATE
por: Vermeulen, Koen, et al.
Publicado: (2022)

Synthesis and Ready to Use Kit Formulation of EDTMP for the Preparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical
por: Mercanoglu, Guldem, et al.
Publicado: (2023)

The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia
por: Calegaro, J U M, et al.
Publicado: (2014)

Comparison of Image Quality of Different Radionuclides Technetium-99m, Samarium-153, and Iodine-123
por: Bouzekraoui, Youssef, et al.
Publicado: (2019)

Does Intravenous Contrast Improve the Diagnostic Yield of Fluorodeoxyglucose Positron-emission Tomography/Computed Tomography in Patients with Head-and-neck Malignancy
por: Barai, Sukanta, et al.
Publicado: (2020)

Do reconstruction filters really effect the volume and ejection fraction calculation with 99(m)Tc-sestamibigated myocardial SPECT?
por: Manish, Ora, et al.
Publicado: (2010)

Preparation and Quality Control of the [(153)Sm]-Samarium Maltolate Complex as a Lanthanide Mobilization Product in Rats
por: Naseri, Zohreh, et al.
Publicado: (2011)

Neutron Activated Samarium-153 Microparticles for Transarterial Radioembolization of Liver Tumour with Post-Procedure Imaging Capabilities
por: Hashikin, Nurul Ab. Aziz, et al.
Publicado: (2015)

Neutron-activated biodegradable samarium-153 acetylacetonate-poly-L-lactic acid microspheres for intraarterial radioembolization of hepatic tumors
por: Wong, Yin-How, et al.
Publicado: (2020)

Production, Quality Control and Pharmacokinetic Studies of (177)Lu-EDTMP for Human Bone Pain Palliation Therapy Trials
por: Bahrami-Samani, Ali, et al.
Publicado: (2012)

Production, quality control, and bio-distribution studies of (159)Gd-EDTMP as a palliative agent for bone pain
por: Arani*, Simindokht Shirvani, et al.
Publicado: (2015)

Preparation and In Vitro Evaluation of Neutron-Activated, Theranostic Samarium-153-Labeled Microspheres for Transarterial Radioembolization of Hepatocellular Carcinoma and Liver Metastasis
por: Wong, Yin How, et al.
Publicado: (2019)

Yttrium-90-EDTMP: a radiotherapeutic agent in the treatment of leukaemias.
por: Keeling, A. A., et al.
Publicado: (1989)

Absorbed dose assessment of (177)Lu-zoledronate and (177)Lu-EDTMP for human based on biodistribution data in rats
por: Yousefnia, Hassan, et al.
Publicado: (2015)

Effectiveness of Radiation Synovectomy with Samarium-153 Particulate Hydroxyapatite in Rheumatoid Arthritis Patients with Knee Synovitis: A Controlled Randomized Double-Blind Trial
por: dos Santos, Marla Francisca, et al.
Publicado: (2009)

Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study
por: Ora, Manish, et al.
Publicado: (2021)

Comparing Estimated and Measured Glomerular Filtration Rate in Children with Posterior Urethral Valve
por: Ora, Manish, et al.
Publicado: (2023)

Production, Quality Control and Pharmacokinetic Studies of (166)Ho-EDTMP for Therapeutic Applications
por: Bahrami-Samani, Ali, et al.
Publicado: (2010)

Energy loss function of samarium
por: Yang, T. F., et al.
Publicado: (2023)

Optimization of Scatter Correction Method in Samarium-153 Single-photon Emission Computed Tomography using Triple-Energy Window: A Monte Carlo Simulation Study
por: Asmi, Hicham, et al.
Publicado: (2020)

The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and $^{225}$Ac in tumor bearing mice
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1996)

Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva)
por: Joob, Beuy, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k2kn6j4okr3fk4ikk3njcev3vd